Scale -


  • Revenue is 2396 Rs Cr; Annual Growth is 15 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 13 %
  • Ebitda is 308 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 12 %
  • PAT is 147 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 11 %
  • Quarterly Revenue is 697 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Ebitda is 80.63 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -


  • PBDIT Margin is 12.86 %; in Top Quartile; Continuous Decline over 3 years
  • PAT Margin is 6.14 %; Continuous Decline over 3 years

Return -


  • ROA is 6.51 %; Continuous Decline over 3 years
  • ROE is 11.19 %; Continuous Decline over 3 years
  • Asset Turnover is 115 %; Continuous Decline over 3 years

Efficiency -


  • Operating cash flow is 65.07 Rs Cr; 5 Year CAGR is 22 %; Annual Decline is -53 %
  • Current Ratio is 1.58; Continuous Decline over 3 years
  • Quick Ratio is 1.06; Continuous Decline over 3 years; in Bottom Quartile

Solvancy -


  • Debt/Equity is 0.31; Annual Growth is 94 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 136 %
  • Total Debt is 408 Rs Cr; Annual Growth is 117 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 164 %
  • Contingent Liabilities is 23.59 Rs Cr; Annual Growth is 1091 %; in Top Quartile; 5 Year CAGR is 73 %
  • Long term Debt is 94.33 Rs Cr; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 21 %; Annual Decline is -59 %
  • Operating cashflow/PAT is 44 %; Annual Decline is -56 %
  • Change in Inventories/Total Expenses is -1 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Current Tax/PAT is 42 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
India’s Rossari registers as gas purification reagent supplier in Azerbaijan (Exclusive)
Rossari Biotech (NSEI:ROSSARI)
India’s Rossari Biotech eyes supplying Turkmen oil, gas sector (Exclusive)
Rossari Biotech Ltd Estimates – NSE:ROSSARI
Rossari Biotech (NSEI:ROSSARI) Stock Forecast & Analyst Predictions
Earnings call transcript: Rossari Biotech misses revenue estimate in Q2 2026
Rossari Biotech Posts Record Quarter Amid Cost Headwinds
Rossari Biotech Q2 FY27 net profit hits Rs. 3.89 Cr
Rossari Biotech Limited (ROSSARI.NS) Q2 2026 Earnings